HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
Sys. Review
Case report on ivonescimab for EGFR-TKI-resistant lung adenocarcinoma with pericardial effusion
One Drug Shrinks Lung Tumors When Others Stop Working
This is a case report and literature review of a 77-year-old female with EGFR-TKI-resistant advanced lung adenocarcinoma and malignant peric…
A 77-year-old woman with advanced lung cancer saw her tumors shrink and dangerous fluid around her heart disappear after trying a new drug c…
Frontiers
May 13, 2026
Oncology
Meta-analysis
TIS categorization stratifies pericardial effusion malignancy risk from 10.8% to 78.6% across categories
New Tool Cuts Cancer Risk Guesswork in Heart Fluid
This meta-analysis evaluated 2,976 pericardial fluid samples using the International System for Reporting Serous Fluid Cytopathology (TIS).
Imagine waking up with chest pain and a doctor ordering a fluid test from your heart.
Apr 10, 2026